Primaa
Latest round
- Seed
Last raised
- Oct 2019
Total raised
- $1.3M
Investors
- 3
About Primaa
Primaa SAS specializes in developing AI-powered diagnostic solutions for cancer, empowering healthcare professionals with advanced tools for accurate and efficient cancer diagnosis. Founded in 2018 in Paris, France, Primaa SAS is dedicated to enhancing cancer diagnostics.981 mn.Primaa's primary product offering is the Cleo platform, an AI-powered software solution designed to assist pathologists in cancer diagnosis, specializing in breast and skin cancer. Cleo utilizes advanced image analysis and deep learning technologies to detect various cancer biomarkers with a high degree of accuracy and speed. This platform supports medical professionals by streamlining the diagnostic process, ultimately guiding personalized treatment plans for patients. Cleo has been validated through clinical studies and has received CE marking, allowing for commercialization across multiple European markets.Primaa operates under a revenue model that includes subscriptions and partnerships with healthcare providers and institutions leveraging its AI solutions. The company engages in direct B2B transactions, where clients, including hospitals and diagnostic labs, integrate Cleo into their diagnostic workflows. This integration enhances their diagnostic capabilities and results in potential cost savings and improved patient outcomes. The structure of these transactions may involve tiered pricing plans based on the volume of cases processed or the specific features of the Cleo platform utilized by the client. The company is working on new features for the Cleo platform to enhance its diagnostic capabilities. Additionally, Primaa plans to expand its market reach into other European countries by 2024, aiming to increase the adoption of its AI diagnostic solutions across the continent.
Who invested in Primaa
3 investors across 1 round
See all investors in Primaa
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 17, 2019
Amount
$1.3M
Investors
Questions about Primaa
Who invested in Primaa?
Primaa has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Primaa raised?
Primaa has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Primaa last raise money?
Primaa's most recent round on record is a Seed, in Oct 2019.
What does Primaa do?
Primaa SAS specializes in developing AI-powered diagnostic solutions for cancer, empowering healthcare professionals with advanced tools for accurate and efficient cancer diagnosis.
Where is Primaa headquartered?
Primaa is headquartered in Paris, France.
Which VCs invest in companies like Primaa?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Balderton Capital and Sofinnova Partners back software companies at Primaa's stage. Their profiles are linked below.
VCs backing software startups at Seed
Raising like Primaa? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.